Mark Adams

author
With over 40 years of experience in health insurance and clinical operations, Mark Adams began his career in insurance broking and dental capitation before transitioning to hospital and clinic management in the UK, US, and Middle East. Mark has run organisations including AXA Healthcare, Denplan, Virgin Healthcare, Gulf Healthcare, and Anglo Arabian Healthcare. Currently, Mark is CEO of Dubai’s leading 5-star hospital, the Clemenceau Medical Center. He also serves on the boards of Johns Hopkins Aramco Healthcare and Tibbiyah in Saudi Arabia. He is also the Chair of Renovo Healthcare, a UK Hospital Group. Mark has previously sat on the boards of the NMC Hospitals, the British Quality Foundation, the London Board of the NSPCC, and has run the leading social care charity Community Integrated Care where he was twice voted Healthcare Leader of the Year in the Charitable sector. He has also advised Prudential on entering the health insurance market and sat on the board of PruHealth (Vitality Healthcare) during the launch of this market challenger.
Opinion

The law of unintended consequences: how regulatory changes can blindside entrepreneurial development in healthcare

The UAE’s healthcare reforms and legislative changes appear to have been well received in many quarters. After all, a closer alignment with healthcare

Read More
Opinion

Risks in healthcare consolidation: do mergers guarantee success?

Competition and over-supply have transformed the GCC healthcare sector and have allowed end users and payers more opportunities to differentiate between market players

Read More
Opinion

Obesity drugs: miracle cure or hidden danger?

When you're dealing with obesity, losing weight can feel like the most important health improvement, no matter what side effects a drug might

Read More
Opinion

Healthcare at home: how technology, innovation and collaboration are shaping chronic-illness treatment

Achieving better health outcomes for chronic illness in Dubai is fast becoming an urgent healthcare priority. From a clinical and financial point of

Read More